Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
Rhea-AI Summary
Stereotaxis (NYSE: STXS) will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the U.S. market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss results and corporate developments, with live and replay access via phone and the investor relations section of the company’s website.
Positive
- None.
Negative
- None.
News Market Reaction – STXS
On the day this news was published, STXS declined 2.00%, reflecting a moderate negative market reaction. Argus tracked a trough of -2.1% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $142.47M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 21 | 2Q26 reporting date | Neutral | -3.0% | Announced first-quarter results date and 4:30 p.m. ET conference call |
| Feb 12 | FY25 reporting date | Neutral | -0.5% | Announced fourth-quarter and full-year results date and conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The two prior earnings-date announcements were followed by negative 24-hour price reactions of -3.03% and -0.49%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis second quarter 2026 financial results conference call |
| When: | Tuesday, August 11, 2026, at 4:30 p.m. ET (1:30 p.m. PT) |
| Dial In Number: | To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 4404741. |
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/. |
| Call Replay: | A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here. |
About Stereotaxis
Stereotaxis, Inc. (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
